An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladder
{{output}}
Objective: To assess efficacy and safety of mirabegron 25 mg/day and 50 mg/day for overactive bladder in Chinese participants. Methods: Partici... ...
